Apollo Healthtech targets listing by Jan-Mar 2027
Apollo Healthtech, a part of Apollo Hospitals, may get listed by early 2027. This move aims to unlock value for shareholders. Promoters will remain the same. Apollo Hospitals reported a strong Q1 with a 42% profit increase. Revenue also grew by 15%. The company plans to add over 4,300 beds in the next few years.
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
Mumbai: Apollo Healthtech , the demerged omni-channel pharmacy and digital health business of Apollo Hospitals , is likely to be listed by January-March 2027, a top company official said Tuesday.Asked if there are plans of a family reorganisation, Apollo Hospitals group chief financial officer Krishnan Akhileswaran told ET, "No, there isn't. It's just a value unlock for shareholders. The promoters of Apollo will also be the promoters of the new company, and they will also be directors in the new company. So, there is no change from that standpoint."Apollo Hospitals, India's largest pan-India hospital chain by revenue, announced its first quarter results post market hours on Tuesday. It posted a 42% on-year rise in first quarter consolidated net profit to ₹433 crore, driven by double-digit growth in all business segments.Revenues for the quarter grew 15% on-year to ₹5,842 crore, driven by higher patient volumes and growth in diagnostic footprint. The company saw 26% rise in earnings before interest, taxes, depreciation, and amortisation to ₹852 crore. It had earlier in the quarter announced spinning off its omni-channel pharmacy and digital health business into a new entity Apollo Healthtech."The application to the stock exchanges have been already made and once their approval is received, we can file to the CCI (Competition Commission of India) and NCLT (National Company Law Tribunal) simultaneously. We expect the listing to happen around January-March of 2027. Some of the NCLT-related approval should come much before that," Akhileswaran elaborated.Apollo Hospitals Enterprise chairman Prathap C Reddy said, "The demerger of our digital health and pharmacy business, approved in the last quarter, is now in the implementation phase. This strategic move will enable focused capital allocation and sharper growth plans with dedicated management teams for both hospital operations and omnichannel healthcare ecosystem."The hospital chain aims to add 4,370 beds through acquisition, brownfield and greenfield expansion over the next 3-4 years, with the first phase of 2,000 beds is already in progress. "Patient numbers across our network increased year-on-year. The quarter saw us announce our ambitious growth strategy to add over 4,300 beds in the next five years with an investment of over ₹7,600 crore," said Dr Reddy.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
2 hours ago
- New Indian Express
Out-of-court, debtor-in-control process to hasten resolution of insolvency cases
NEW DELHI: A lender-initiated, debtor-in-control resolution process, as proposed under the Insolvency Bill, is a big step towards faster resolution of insolvency cases in India, feel experts. The Insolvency & Bankruptcy Code (Amendment) Bill, 2025, which was tabled in parliament on Tuesday, has proposed the 'creditor-initiated insolvency resolution process', under which a resolution process can be initiated on approval of 51% of the financial creditors. However, the management of the company continues to be vested with the existing board of directors of the company under the supervision of the resolution professional appointed by financial creditors. The delay in getting approval of the adjudicating authority (NCLT) is the biggest reason for delay of the whole resolution process. In order to address this issue, the Bill proposes that a creditor-initiated resolution process can be initiated without the need for NCLT approval. 'The process contains provisions for approaching the adjudicating authority at different stages but not for the initiation of the process unless objected by the corporate debtor,' says Surendra Raj, partner, Grant Thornton.
Time of India
2 hours ago
- Time of India
‘Don't think US tariffs will…': S&P confident Donald Trump's tariffs won't impact India's growth; here's why
S&P projects India's GDP growth to remain steady at 6.5% in the ongoing fiscal year. (AI image) The Donald Trump administration's move to impose a total of 50% tariffs (25% base tariff + 25% additional tariff for India's crude oil trade with Russia) are unlikely to have any significant impact on the Indian economy, believes S&P Global Ratings. In fact, S&P has even said that the US tariffs pose no threat to the positive sovereign outlook for India. S&P had enhanced its outlook on India's 'BBB-' sovereign rating to positive in May 2022, attributing it to strong economic performance. Trump declared on August 6 that all Indian imports would face an additional 25% tariff, supplementing the existing 25% duty, resulting in a total tariff of 50% effective from August 27. The White House attributed this decision to India's ongoing procurement of Russian oil. Also Read | 'Can't cross some red lines': Government officials tell Parliamentary Panel on India-US trade talks; focus on export diversification amidst Trump tariffs Why US tariffs are unlikely to hit India's growth story The S&P Global Ratings Director YeeFarn Phua said on Wednesday that India's growth would remain unaffected by Trump's tariffs, given its limited trade-oriented economic structure, whilst maintaining a positive sovereign ratings outlook. According to a PTI report, when questioned about potential risks to India's positive outlook due to US tariffs, YeeFarn explained that India's economy would remain stable, noting that its export exposure to the US represents merely 2% of GDP, indicating minimal trade dependence. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Victoria Principal Is Almost 75, See Her Now Boite A Scoop Undo "I don't think the tariffs imposed on India will have an impact in terms of economic growth, largely because India is not a very trade-oriented economy. And if you look at India's exposure to the US in terms of exports to GDP, it is just about 2%,' YeeFarn Phua was quoted as saying. S&P projects India's GDP growth to remain steady at 6.5% in the ongoing fiscal year, matching the previous financial year's performance. YeeFarn noted that significant export sectors to the US, including pharmaceuticals and consumer electronics, remain unaffected by Trump's tariff moves. Also Read | Donald Trump tariffs: How much will India's fuel bill rise if it stops Russian crude oil imports & where would it buy from? Explained "Over the longer term, we don't think this (higher tariffs) will be a big hit (on India's economy), and therefore, the positive outlook on India remains," YeeFarn said at a Webinar on Asia-Pacific Sovereign Ratings. Addressing concerns about US tariffs affecting investment flows into India, he explained that businesses have implemented the 'China plus one' strategy in recent years, establishing operations in India primarily to serve the local market. "Many (businesses) are going there not because they are looking to export just to the US. Many of them are going there because of the huge domestic market as well. An emerging middle class is getting even for those who are looking to invest more in India and looking to export, it might not necessarily be the US market," YeeFarn said. India-US trade facts In 2021-25, the United States emerged as India's leading trading partner. The US contributed approximately 18% to India's overall goods exports, whilst accounting for 6.22% of imports and 10.73% of bilateral trade. India maintained a favourable trade balance with the United States, recording a surplus of $35.32 billion in goods during 2023-24. This figure increased to $41 billion in 2024-25. The bilateral trade between India and the United States totalled $186 billion in 2024-25. During this period, India's exports to the US amounted to $86.5 billion, whilst imports were valued at $45.3 billion. The ongoing trade negotiations between India and the US have hit a bump over the former's clear stance of not opening its agricultural and dairy sectors to American products. Additionally, Trump's desire to end the Russia-Ukraine conflict has led to India feeling the heat of 25% additional tariffs for its crude oil imports as a pressure tactic on Russian President Vladimir Putin. Also Read | Donald Trump's 50% tariffs on India spark outrage: Calls for boycotting US-based brands grow on social media; self-reliance in focus Stay informed with the latest business news, updates on bank holidays , public holidays , current gold rate and silver price .
The Hindu
2 hours ago
- The Hindu
Farmers, workers protest FTAs, warn of corporate takeover of agriculture
Farmer and worker unions on Wednesday staged protests against the Union government's free trade agreements (FTAs), alleging they are damaging India's agricultural sector. As part of the 'Quit Corporates' call given by the Samyukt Kisan Morcha and the Joint Committee of Central Trade Unions, farmers, labourers, tenant farmers, and agricultural workers assembled here, burning effigies of Prime Minister Narendra Modi and U.S. President Donald Trump. Speakers compared the India-U.S. FTAs to earlier GATT, Dunkel, and WTO deals, claiming they favour corporate interests at the expense of farmers. They alleged the agreements allow foreign companies to dominate machinery sales and agri produce markets, citing rules such as scrapping 10-year-old tractors as exploitative. Protestors warned that these pacts could devastate farming, transfer land to corporates, and hurt aquaculture through U.S.-imposed tariffs. Their demands included scrapping Trump-era tariffs, implementing the Swaminathan Commission's MSP recommendations for all crops, waiving loans for farmers, tenants, and agricultural labourers, reversing anti-worker labour laws, and protecting public sector enterprises. The protest was addressed by Andhra Pradesh Rythu Sangham State joint secretary K. Srinivas, BKMY State vice president Bandi Venkateswara Rao, IFTU district secretary Badda Venkata Rao, Rythu Coolie Sangham leader Sheikh Basha, AIKS general secretary S.K. Ghouse, CITU district president R. Lingaraju, Congress Kisan Cell leader Rajanala Ram Mohan Rao, and AITUC district president Reddy Srinivas Dange.
